PMDA — authorised 23 June 2021
- Marketing authorisation holder: ALNYLAM JAPAN K.K
- Status: approved
🇯🇵 Givlaari in Japan
PMDA authorised Givlaari on 23 June 2021
Marketing authorisation
Givlaari in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in Japan
Frequently asked questions
Is Givlaari approved in Japan?
Yes. PMDA authorised it on 23 June 2021.
Who is the marketing authorisation holder for Givlaari in Japan?
ALNYLAM JAPAN K.K holds the Japanese marketing authorisation.